Premature ejaculation improves with antidepressants

buy fluoxetine 20 mg.gif

Viagra and, in addition, Prozac

Clinical trials show that sometimes sex is completely dependent on taking medication. The latest issue of the Journal of Urology published an article suggesting that premature ejaculation can be improved by taking antidepressants of the same family as Prozac. Medications for erectile dysfunction as well as medications for the other most common dysfunction in men, excessive ejaculation rate.

A team from St. Luke's Hospital in Sydney, Australia, led by By Dr. Chris McMahon Studied 37 men between the ages of 19 and 72 who complained of premature ejaculation. The study evaluated the role of sertraline, an antidepressant of the same nature as fluoxetine (Prozac), which inhibits the neurotransmitter serotonin reuptake in the brain. Compared to placebo, sertraline showed statistically significant results. Men who, before treatment, ejaculated during intercourse an average of 30 seconds after intercourse began were able to prolong this period by an average of just over three minutes. This result appeared about two weeks after starting treatment. None of the study subjects received psychological counseling, only medication. A total of 29 patients who achieved satisfactory results while taking sertraline continued taking the drug for seven months. Tolerability of the drug was generally good.

Treatment with new antidepressants sometimes has side effects on sexual life and leads to impotence. For this reason, many urologists use this type of drug in patients without depressive problems to increase the delay between penetration and ejaculation, thereby partially solving one of the most common sexual dysfunctions in men.

In addition, at a recent meeting of the American Psychiatric Association in Toronto, two studies of a new type of antidepressant that may be as successful as "Prozac" And other drugs of this type.

A team from the University of Wales, led by Dr. David Healey, treated a group of 302 patients with severe depression with two types of drugs. Half of them were given fluoxetine and the other half were given reboxetine, a drug that, instead of inhibiting serotonin reuptake in the brain, inhibits norepinephrine reuptake. This neurotransmitter is involved in depression in the same way as serotonin.

Although both drugs had similar effects on the most severe symptoms of depression, reboxetine was more effective than fluxetine at improving the social adjustment of depressed people. A study from Barcelona Hospital Hospital, also presented in Toronto, had similar results.

The emergence of these new products heralds the emergence of psychoactive drugs with hitherto unknown specifics.